ANDA Review Time Could Be Cut By Adding 50 FTEs Without User Fees - Barr

18 Jun 2001

• By The Pink Sheet

FDA's Office of Generic Drugs could reduce ANDA review time by adding 50 full time equivalents, Barr Laboratories CEO Bruce Downey told the House Commerce/Health Subcommittee June 13.

ANDA Review Time Could Be Cut By Adding 50 FTEs Without User Fees - Barr

More from Archive

More from Pink Sheet